Q1 2023 EPS Estimates for Health Catalyst, Inc. Reduced by Analyst (NASDAQ:HCAT)

Health Catalyst, Inc. (NASDAQ:HCATGet Rating) – SVB Leerink decreased their Q1 2023 earnings per share (EPS) estimates for shares of Health Catalyst in a research note issued to investors on Wednesday, March 1st. SVB Leerink analyst S. Davis now forecasts that the company will post earnings per share of ($0.33) for the quarter, down from their previous forecast of ($0.26). SVB Leerink currently has a “Outperform” rating and a $17.00 target price on the stock. The consensus estimate for Health Catalyst’s current full-year earnings is ($1.42) per share. SVB Leerink also issued estimates for Health Catalyst’s Q2 2023 earnings at ($0.28) EPS, Q3 2023 earnings at ($0.44) EPS, Q4 2023 earnings at ($0.27) EPS, FY2023 earnings at ($1.31) EPS and FY2024 earnings at ($1.17) EPS.

Several other equities research analysts have also issued reports on the stock. Royal Bank of Canada lifted their price objective on shares of Health Catalyst from $9.00 to $15.00 and gave the company a “sector perform” rating in a research note on Wednesday, March 1st. Raymond James boosted their price target on shares of Health Catalyst from $15.00 to $18.00 and gave the company a “strong-buy” rating in a report on Thursday. BTIG Research dropped their price objective on Health Catalyst to $17.00 in a research note on Tuesday, November 15th. Canaccord Genuity Group decreased their price objective on shares of Health Catalyst from $19.00 to $15.00 and set a “buy” rating on the stock in a research note on Wednesday, November 9th. Finally, Piper Sandler reduced their target price on shares of Health Catalyst from $11.00 to $8.00 in a research report on Wednesday, November 9th. Six analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $18.00.

Health Catalyst Trading Up 2.1 %

Shares of NASDAQ:HCAT opened at $14.13 on Monday. The company has a quick ratio of 4.87, a current ratio of 5.18 and a debt-to-equity ratio of 0.53. Health Catalyst has a 12-month low of $6.40 and a 12-month high of $27.98. The firm has a fifty day moving average of $12.77 and a two-hundred day moving average of $11.05. The firm has a market capitalization of $788.60 million, a P/E ratio of -5.31 and a beta of 1.26.

Institutional Investors Weigh In On Health Catalyst

Several institutional investors and hedge funds have recently added to or reduced their stakes in HCAT. State of Wyoming boosted its position in Health Catalyst by 148.6% in the fourth quarter. State of Wyoming now owns 8,916 shares of the company’s stock worth $95,000 after purchasing an additional 5,329 shares during the last quarter. Public Employees Retirement System of Ohio raised its holdings in Health Catalyst by 66.5% during the 4th quarter. Public Employees Retirement System of Ohio now owns 103,745 shares of the company’s stock valued at $1,103,000 after acquiring an additional 41,426 shares during the period. State of Wisconsin Investment Board raised its stake in shares of Health Catalyst by 19.6% during the 4th quarter. State of Wisconsin Investment Board now owns 126,942 shares of the company’s stock valued at $1,349,000 after purchasing an additional 20,842 shares during the period. Symmetry Peak Management LLC purchased a new position in Health Catalyst during the fourth quarter valued at approximately $159,000. Finally, Shay Capital LLC purchased a new stake in shares of Health Catalyst in the fourth quarter worth $638,000. Hedge funds and other institutional investors own 90.55% of the company’s stock.

About Health Catalyst

(Get Rating)

Health Catalyst, Inc engages in the provision of data and analytics technology and services to healthcare organizations. It operates through the Technology, and Professional Services segments. The Technology segment includes its data platform, analytics applications, and support services. The Professional Services segment combines analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers.

See Also

Receive News & Ratings for Health Catalyst Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Catalyst and related companies with MarketBeat.com's FREE daily email newsletter.